“A map does not just chart, it unlocks and formulates meaning; it forms bridges between here and there, between disparate ideas that we did not know were previously connected.” Reif Larsen, The Selected Works of T.S. Spivet

This is an invitation – get your name on the European Nanomedicine Map

The NanoMed Map is a real instrument for any nanomedicine enthusiast to trigger new collaborations and long-term partnerships between nanomedicine actors and beyond.

Initiated by the EU project NANOMED2020, the European Nanomedicine Map provides thorough insights into the existing nanomedicine community by introducing on a single chart all the ecosystem‘s actors in Europe and beyond. This reference tool aims at increasing awareness, providing new networking opportunities, and at initiating fruitful partnerships.

A first step in the process of apprehending a discipline is to get a deeper view and understanding of the actors involved in this field.

With the European NanoMed Map, the nanomedicine community wins its own exploration tool displaying the top 1,500 European actors, including stakeholders of nanomedicine as such, research centres, academia, SMEs and industries, healthcare providers, public and funding authorities, associations, clusters and infrastructures but also actors for which, nanomedicine will be an field of growing interest in the coming years.

[button size=”medium” align=”right” link=”http://www.etp-nanomedicine.eu/public/european-nanomedicine-map” color=”red”]READ MORE, go to website[/button]

Lab-on-a-Chip European Congress, 10–11 March 2014 • Berlin, Germany

Poster Submission Deadline – 11 February, 2014!

During the last decade, nano and micro-technology has become an important industry. It is a rapidly growing, highly interdisciplinary field at the interface of physics, engineering, chemistry and biology. The pico to nanoliter scale not only allows a high degree of parallelisation, but also offers superb control. Small objects such as cells can be exposed to unique conditions, facilitating entirely novel approaches, which will be discussed at the conference.

The 6th Lab-on-a-Chip European CongressPoster Submission Deadline – 11 February, 2014 [button size=”medium” align=”right” link=”https://selectbiosciences.com/login.aspx?redirect=/conferences/submissionform.aspx?conf=LOACEC2014&type=Poster” color=”blue”]Abstract for consideration[/button]

1st International Conference on
Micro & Nanofluidics
Fundamentals and Applications
18-21 May 2014 University of Twente – The Netherlands

Welcome to Flow 14

Micro- and nanofluidics has considerably matured over the last 2 decades. This holds both for the fundamental understanding of the flow on a micro- and nanoscale and for the applications in industry. Various start-up companies have been founded and global players have realized the importance of the field. Applications can be found in the chip-industry, medical diagnostics, drug development and delivery, ink-jet printing, … Interestingly enough, more fundamentally oriented and more application oriented scientists in this field have stayed rather separate, generally visiting different conferences. The aim of the present 3-day international Flow14 conference is to overcome this separation and to bridge the gap between these two branches of micro- and nanofluidics.
[button size=”medium” link=”http://www.flow14conference.com/” linkTarget=”_blank” color=”blue” bgColor=”#BB002E” textColor=”#F4F4F4″ hoverBgColor=”#BB002E” hoverTextColor=”#F4F4F4″]Go to the website[/button]

The British Society for Nanomedicine (BSNM) is proud to collaborate with SELECTBIO in the organisation of Nanomedicine 2014. BSNM is a registered charity, created to allow open access for industry, academia, clinicians and the public to news and details of on-going nanomedicine research throughout the UK and beyond. A key aim of BSNM is the provision of forums for scientists to disseminate their latest advances and highlight their work to the wider scientific community. The exciting Nanomedicine 2014 programme will provide insight across a number of emerging nanotechnologies that span from treatment to diagnosis. The programme includes the use of solid drug nanosuspensions for improving oral bioavailability and for sustained release formulations, recent developments in targeting nanoparticles through the use of aptamers conjugated to their surface and progress in siRNA delivery as well as cell and particle imaging. The Conference Chair is Dr Andrew Owen, Professor of Pharmacology and Chair of the British Society for Nanomedicine, University of Liverpool.

Attending this event will provide you with excellent opportunities for networking with like minded peers, helping you to find solutions and build collaborations.

[button align=”left” link=”http://selectbiosciences.com/conferences/registration.aspx?conf=NMUK2014″ linkTarget=”_self” color=”blue” width=”81″]Register[/button]

Check out our 2for1 offer!

This is the second phase survey of NANOMED 2020, dedicated to the analysis and optimization of the nanomedicine value chain and development process,

This survey has been designed to give complementary information to a previous work on establishing the nanomed milestones, with the objectives to:
·        identify the main barriers and needs along each step of the value chain, from idea and research all the way to market and commercialisation.

·        assess the interplay between the different stakeholders involved and the main differences of perspectives at the key interfaces

·        provide all participants with the possibility to comment and endorse the milestones and checklists established so far by the NanoMed2020 consortium

Go to the survey:
https://www.vdivde-it.de/mrIWeb/mrIWeb.dll?I.Project=NANOMED2020_SECOND_PHASE

The aim of this survey is to gather key insights into the nanomedicine development process in order to identify the main barriers and needs along each step of the value chain, from idea and research all the way to market and commercialisation.

Focusing on each relevant category of stakeholder, the data will provide a major opportunity to assess the interplay between the different stakeholders involved and the main differences of perspectives at the key interfaces.

Finally, this survey will provide all participants with the possibility to comment and endorse the milestones and checklists established so far by the NanoMed2020 consortium to ensure successful development and uptake from idea to product on the market.

About NanoMed 2020:The NANOMED2020 Coordination and Support Action under the FP7-Health started in September 2012 for a duration of 18 months and aims at federating the nanomedicine community in Europe and delivering concrete recommendations to the European Commission to push forward the field of nanomedicine under Horizon 2020.

Save the date – Oct.1st-2nd! ETPN Annual Event and General Assembly 2013

http://www.etp-nanomedicine.eu/public/news-events/events/etp-nanomedicine-general-assembly-2013/etp-nanomedicine-general-assembly-2013/?searchterm=None